Psoriasis, erythema nodosum, and nummular eczema onset in an ankylosing spondylitis patient treated with infliximab [2]

Scandinavian Journal of Rheumatology

Volumn 36, Issue 5, 2007, Pages 403-404

  Sedie, A Delle ^a   Bazzichi, L ^a   Bombardieri, S ^a   Riente, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; GALLIUM; HLA B27 ANTIGEN; INFLIXIMAB; SALAZOSULFAPYRIDINE; STEROID; TECHNETIUM 99M;

ANALGESIA; ANKYLOSING SPONDYLITIS; ARTHRALGIA; DRUG WITHDRAWAL; ERYTHEMA NODOSUM; EXERCISE; HUMAN; IMMOBILIZATION; LABORATORY TEST; LETTER; LOW BACK PAIN; NUMMULAR DERMATITIS; PRIORITY JOURNAL; PSORIASIS; SACROILIITIS; SCINTIGRAPHY; SPINE MOBILITY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ECZEMA; ERYTHEMA NODOSUM; FEMALE; HUMANS; PSORIASIS; SPONDYLITIS, ANKYLOSING;

EID: 35648973826     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701288173     Document Type: Letter

References (10)

1. Brion PH, Mittal-Henkle A, Kalunian KC. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med 1999;131:634.
2. Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002;138:1258-9.
3. Beuthien W, Mellinghoff HU, von Kempis J. Skin reaction to adalimumab. Arthritis Rheum 2004;50:1690-2.
4. Dereure O, Guillot B, Jorgensen C, Cohen JD, Combes B, Guilhou JJ. Psoriatic lesions induced by antitumour necrosis factor treatment: two cases. Br J Dermatol 2004;150:506-7.
5. Haibel H, Spiller I, Strasser C. Unexpected new onset or exacerbating of psoriasis in treatment of active ankylosing spondylitis with TNF blocking agents. Ann Rheum Dis 2004;63(Suppl):405.
6. Grinblat B, Scheinberg M. Unexpected onset of psoriasis during infliximab treatment: comment on the article by Beuthien et al. Arthritis Rheum 2005;52:1333-42.
7. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy. Arthritis Rheum 2005;52:2513-18.
8. Flendrie M, Vissers W, Creemers M, de Jong E, van de Kerkhof P, van Riel P. Dermatological condition during TNF-alpha blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 2005;7:R666-76.
9. Kary S, Worm M, Audring H, Huscher D, Renelt M, Sorensen H, et al. New onset or exacerbation of psoriatic skin lesions in patients with definitive rheumatoid arthritis receiving tumour necrosis factor antagonists. Ann Rheum Dis 2006;65:405-7.
10. Adams DR, Buckel T, Sceppa JA. Infliximab associated new-onset psoriasis. J Drugs Dermatol 2006;5:178-9.